肾细胞癌
酪氨酸激酶抑制剂
医学
内科学
肿瘤科
酪氨酸激酶
癌
癌症研究
癌症
受体
作者
Hiroki Ishihara,Yuki Nemoto,Shinsuke Mizoguchi,Koichi Nishimura,Hironori Fukuda,Kazuhiko Yoshida,Hiroaki Shimmura,Yasunobu Hashimoto,Junpei Iizuka,Tsunenori Kondo,Toshio Takagi
出处
期刊:Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期:2025-03-28
卷期号:45 (4): 1643-1652
标识
DOI:10.21873/anticanres.17545
摘要
The implementation of IO therapies has enhanced tumor response rates among patients within the IMDC favorable-risk group, although extended follow-up is necessary to ascertain any survival benefits.
科研通智能强力驱动
Strongly Powered by AbleSci AI